| Filed | Description | |
|---|---|---|
| 12/23/24 | 1.01 Material Agreement | → |
| 2/15/24 | 1.011.02 Material Agreement · Agreement Terminated | → |
| 5/5/23 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 10/14/21 | 1.012.03 Material Agreement · New Debt Obligation | → |
| 5/15/20 | 1.012.03 Material Agreement · New Debt Obligation | → |
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management.